MECHANISM-GUIDED PHARMACOTHERAPY FOR CARDIOMETABOLIC MULTIMORBIDITY: FROM PATHOPHYSIOLOGY TO PHENOTYPE-PRIORITIZED TREATMENT

Descargar Publicación
Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it Nutrición y riñón: Más allá de la restricción